NCT05391932

Brief Summary

The proposed research is relevant to vestibular science and the general public because age-related vestibular hypofunction is a major contributor to poor balance, falls, and other adverse health outcomes. In this investigation the investigators will: 1) assess the preliminary efficacy of a novel intervention system for improving vestibular function and dizziness in community-dwelling older adults, 2) assess the safety and feasibility of the this system, and 3) assess the acceptability and implementation potential of this system, prior to a large-scale, R01-level investigation.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

May 11, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 26, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

2.9 years

First QC Date

May 11, 2022

Last Update Submit

April 1, 2024

Conditions

Keywords

Rehabilitationdynamic visual acuitygaze stabilitypostural stabilitydizziness

Outcome Measures

Primary Outcomes (1)

  • Computerized Dynamic Visual Acuity (cDVA)

    computerized measure of functional gaze stability

    through study completion, an average of 12 weeks

Secondary Outcomes (6)

  • Instrumented postural sway assessment

    through study completion, an average of 12 weeks

  • Video head impulse testing (vHIT)

    through study completion, an average of 12 weeks

  • Functional Gait Assessment (FGA)

    through study completion, an average of 12 weeks

  • Activities-specific Balance Confidence Scale (ABC)

    through study completion, an average of 12 weeks

  • Dizziness Handicap Inventory (DHI)

    through study completion, an average of 12 weeks

  • +1 more secondary outcomes

Other Outcomes (9)

  • Two minute walk test (2MWT)

    through study completion, an average of 12 weeks

  • Community Ambulatory Task (CAT)

    through study completion, an average of 12 weeks

  • Life Space Mobility Assessment (LSA)

    through study completion, an average of 12 weeks

  • +6 more other outcomes

Interventions

MINDGAPSBEHAVIORAL

Utilize wearable sensor technology to provide simple, precise measures of gaze and postural stability, as well as remote monitoring of patient adherence to vestibular exercises during a 6-week training period. Additionally, NIH Toolbox data will be used to display patient status compared to normative values and to indicate progress over time relative to measurement error.

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Reports issues with dizziness or imbalance
  • Ability to stand independently
  • Presence of peripheral vestibular hypofunction as indicated by examination with video nystagmography, video head impulse testing, or dynamic visual acuity testing.

You may not qualify if:

  • cervical spine disorders
  • vertebral or carotid artery dissection
  • blindness
  • peripheral or central oculomotor palsy
  • centrally mediated vestibular dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Montana

Missoula, Montana, 59812, United States

RECRUITING

MeSH Terms

Conditions

Dizziness

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Brian J Loyd, PhD

CONTACT

Andy Kittelson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-cohort double-baseline design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 11, 2022

First Posted

May 26, 2022

Study Start

May 11, 2022

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

April 3, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations